The Healthcare Technology Report recently unveiled its Top 25 Women Leaders in Biotechnology for 2023, featuring five Indian-Americans: Brinda Balakrishna, Rachna Khosla, Avni Santani, Sulagna Bhattacharya, and Shreya Jani. Recognized for their contributions to global health programs, they lead successful biotech companies.
Brinda Balakrishna, BioMarin Pharmaceutical’s Chief Business Development Officer, has been pivotal in global biotech initiatives, leveraging experience from Vision Medicines. With backgrounds at McKinsey & Genzyme, she holds degrees from MIT and Harvard Medical School.
Rachna Khosla, Amgen’s Senior VP of Business Development since September 2021, drives success through strategic partnerships. Her extensive experience includes roles at Lazard, Credit Suisse, Sanofi Aventis, JP Morgan Chase, and Salomon Brothers. She holds degrees from Barnard College and Columbia Business School.
Avni Santani, Chief Genomics Officer at LetsGetChecked, specializes in digital healthcare solutions. Former CMO at Veritas Genetics, she influences clinical development plans. With a PhD from Texas A&M University, she holds board certification from ABMGG.
Sulagna Bhattacharya, CEO of Nanoscope Therapeutics, brings expertise in gene therapies for retinal degenerative diseases. Her background includes management consulting at Deloitte and Hitachi Consulting. She holds international patents and co-founded successful biotech companies.
Shreya Jani, SVP of Corporate Affairs at BeiGene, leads the Global Health Equity initiative. Serving on the Board of the National Partnership for Women and Families, Jani has a history of advocacy, holding degrees from New York University.
